Home

Ham holte positie aspirin dose for stroke prevention tempo beddengoed mooi zo

Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family  Medicine
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine

Primary and Secondary Prevention of Ischemic Stroke and Cerebral  Hemorrhage: JACC Focus Seminar | Journal of the American College of  Cardiology
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar | Journal of the American College of Cardiology

Antiplatelet Therapies After Ischemic Stroke - Practical Neurology
Antiplatelet Therapies After Ischemic Stroke - Practical Neurology

Contemporary antiplatelet therapy for secondary stroke prevention: a  narrative review of current literature and guidelines | Stroke and Vascular  Neurology
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines | Stroke and Vascular Neurology

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM

Frontiers | Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke:  A Clinical Review
Frontiers | Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review

What is the best medical therapy for the secondary prevention of stroke? -  The Hospitalist
What is the best medical therapy for the secondary prevention of stroke? - The Hospitalist

Neurologist P - [General practice] Secondary Stroke Prevention 2019  https://www.facebook.com/neurologistp/photos/a.655820934559216/1635536263254340/?type=3&permPage=1......  Early Management of Patients With Acute Ischemic Stroke: 2019 6.  In-Hospital ...
Neurologist P - [General practice] Secondary Stroke Prevention 2019 https://www.facebook.com/neurologistp/photos/a.655820934559216/1635536263254340/?type=3&permPage=1...... Early Management of Patients With Acute Ischemic Stroke: 2019 6. In-Hospital ...

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus  aspirin for high-risk patients with atrial fibrillation: Stroke Prevention  in Atrial Fibrillation III randomised clinical trial - The Lancet
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial - The Lancet

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute  Ischemic Stroke or Transient Ischemic Attack | Neurology
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology

Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention  Based on Real‐World Data | Journal of the American Heart Association
Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data | Journal of the American Heart Association

Aspirin After Acute Ischemic Stroke | AAFP
Aspirin After Acute Ischemic Stroke | AAFP

Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family  Medicine
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine

Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic  Cerebrovascular Disease: JACC Scientific Expert Panel | Journal of the  American College of Cardiology
Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel | Journal of the American College of Cardiology

PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor  and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale  and design | Semantic Scholar
PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar

Frontiers | Aspirin for Primary Stroke Prevention; Evidence for a  Differential Effect in Men and Women
Frontiers | Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel:  Subanalysis of the CSPS.com Trial | Stroke
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial | Stroke

New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a  History of Heart Attack, AFib, Stroke or Vascular Stenting | DAIC
New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a History of Heart Attack, AFib, Stroke or Vascular Stenting | DAIC

Aspirin for Primary Prevention of Cardiovascular Events - ScienceDirect
Aspirin for Primary Prevention of Cardiovascular Events - ScienceDirect

Drugs in secondary stroke prevention
Drugs in secondary stroke prevention

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke  prevention | Nature Reviews Cardiology
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention | Nature Reviews Cardiology

Prevention of First and Recurrent Stroke (Section VI) - The Stroke Book
Prevention of First and Recurrent Stroke (Section VI) - The Stroke Book

Commonly used medications for stroke prevention after TIA | Download Table
Commonly used medications for stroke prevention after TIA | Download Table

Commonly used medications for stroke prevention after TIA | Download Table
Commonly used medications for stroke prevention after TIA | Download Table

PDF) Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An  Indication-Specific Review of the Literature
PDF) Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An Indication-Specific Review of the Literature

Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use  Patterns and Impact Across Race and Ethnicity in the Southern Community  Cohort Study | Journal of the American Heart Association
Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association